Poster presentation at American Thoracic Society International Conference 2024: Baseline characteristics from the IMPAHCT trial of AV-101, inhaled imatinib, in subjects with pulmonary arterial hypertension May 21, 2024 Supporting Materials View Poster 2.5 MB
